Pfizer
Building A Dividend Growth Portfolio from Scratch in Today’s Expensive Market
2021-03-17
Introduction Building A Dividend Growth Portfolio Before we talk about a dividend growth portfolio, the stock market as measured by the S&P 500 is at an all-time high. However, that is not what concerns me. What I am worried about is the extremely high relative valuation of the market. To be clear, the market can […]
Is the New Pfizer an Attractive Investment?
2020-02-25
Introduction Pharmaceutical giant Pfizer (PFE) is a company in transition that will soon be smaller but hopefully more profitable. Since many of their established drugs are coming off patent, the company is divesting its older drug platform under the Upjohn brand and selling it to Mylan a leading generic pharmaceutical company. Pfizer believes that this […]
Pfizer Inc. Invest For Attractive Valuation and The 4% Dividend Yield
2017-02-22
Investment Thesis Pfizer Inc (PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion. The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%. Pfizer is awarded an S&P credit rating of AA and possesses a modest debt to capital ratio […]